Susanna Schraen-Maschke

Author PubWeight™ 10.22^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.	Curr Alzheimer Res	2012	1.41
2	Biochemistry of Tau in Alzheimer's disease and related neurological disorders.	Expert Rev Proteomics	2008	1.21
3	Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.	Neurobiol Dis	2011	1.00
4	Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.	J Biol Chem	2011	0.94
5	A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1.	Ann Neurol	2002	0.88
6	Association of plasma Aß peptides with blood pressure in the elderly.	PLoS One	2011	0.86
7	Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease.	Neurosci Lett	2004	0.84
8	MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1.	J Neurol	2012	0.81
9	Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels.	PLoS One	2011	0.80
10	A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer's diagnosis.	Curr Alzheimer Res	2013	0.80
11	Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease.	Acta Neuropathol	2003	0.79
12	[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].	Therapie	2010	0.75